Evofem Biosciences, Inc. Uncategorized Contracts & Agreements

35 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Support Agreement, by and between the Company and the Investor, dated as of October 28, and October 30, 2024
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2024
Definitive Agreement by and between the Company and Aditxt, Inc
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2023
Form of Restructuring Agreement
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2023
Offer Letter, by and between the Registrant and Ivy Zhang, dated as of April 10, 2023
Evofem Biosciences, Inc.
Pharmaceuticals
2023
Form of Right
Evofem Biosciences, Inc.
Pharmaceuticals
NY
2022
Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934
Evofem Biosciences, Inc.
Pharmaceuticals
2022
Evofem Biosciences, Inc
Evofem Biosciences, Inc.
Pharmaceuticals
CA
2021
Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934
Evofem Biosciences, Inc.
Pharmaceuticals
2021
Letter Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health Technology Fund...
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2020
Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934
Evofem Biosciences, Inc.
Pharmaceuticals
2020
Form of Repricing Letter Agreement
Evofem Biosciences, Inc.
Pharmaceuticals
2019
Form of Repricing Letter Agreement
Evofem Biosciences, Inc.
Pharmaceuticals
2019
Twelfth Amendment, dated as of December 4, 2017, by and between Neothetics, Inc. and LJ Gateway Office LLC
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Consent to Sub-Sublease, dated as of January 30, 2015, by and among Evofem Biosciences, Inc., Kilroy Realty, L.P., Relational Investors LLC and WomanCare Global Trading, Inc
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2017
Side Letter, dated as of October 11, 2017, by and between Evofem Biosciences, Inc. and Woodford Investment Management Limited
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Amended Offer Letter, dated as of November 16, 2015, by and between the Evofem Biosciences, Inc. and Justin J. File
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Offer Letter, dated as of March 8, 2015, as amended, by and between Evofem Biosciences, Inc. and Justin J. File
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Offer Letter, dated as of October 16, 2014, by and between Evofem Biosciences, Inc. and Saundra Pelletier
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Offer Letter, dated as of April 15, 2015, by and between Evofem Biosciences, Inc. and Kelly Culwell, M.D
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Second Amendment to Stockholder Agreement, dated as of July 28, 2017, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein
Evofem Biosciences, Inc.
Pharmaceuticals
2017
First Amendment to Stockholder Agreement, dated as of July 13, 2016, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Stockholder Agreement, dated as of November 25, 2015, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2017
Form of Lock-Up Agreement
Evofem Biosciences, Inc.
Pharmaceuticals
2017
Form of Support Agreement, by and between Evofem Biosciences, Inc. and certain of its stockholders
Evofem Biosciences, Inc.
Pharmaceuticals
DE
2017
ELEVENTH AMENDMENT
Evofem Biosciences, Inc.
Pharmaceuticals
2017
SECOND AMENDMENT
Evofem Biosciences, Inc.
Pharmaceuticals
2016
SECOND AMENDMENT
Evofem Biosciences, Inc.
Pharmaceuticals
2016
NEOTHETICS, INC. STOCKOPTION AGREEMENT
Evofem Biosciences, Inc.
Pharmaceuticals
CA
2014
FIRST AMENDMENT
Evofem Biosciences, Inc.
Pharmaceuticals
2014
Additional abbreviations may also be used though not in the above list.
Evofem Biosciences, Inc.
Pharmaceuticals
2014
LITHERA, INC. 9191 Towne CentreDrive San Diego, CA 92122 August 12, 2014
Evofem Biosciences, Inc.
Pharmaceuticals
2014
LITHERA, INC. 9191 Towne CentreDrive San Diego, CA 92122 July 3, 2014
Evofem Biosciences, Inc.
Pharmaceuticals
2014
NINTH AMENDMENT
Evofem Biosciences, Inc.
Pharmaceuticals
2014
CONTRACT NO. 0702/12
Evofem Biosciences, Inc.
Pharmaceuticals
NY
2014
DECEMBER 12, 2012 TECHNOLOGY TRANSFER AGREEMENT By and Between DOMAIN RUSSIAINVESTMENTS LIMITED And LITHERA, INC.
Evofem Biosciences, Inc.
Pharmaceuticals
CA
2014